Screening of Bioactive Peptides Using an Embryonic Stem Cell-Based Neurodifferentiation Assay
Journal Title: The AAPS Journal - Year 2014, Vol 16, Issue 3
Abstract
Differentiation of pluripotent stem cells, PSCs, towards neural lineages has attracted significant attention, given the potential use of such cells for in vitro studies and for regenerative medicine. The present experiments were designed to identify bioactive peptides which direct PSC differentiation towards neural cells. Fifteen peptides were designed based on NCAM, FGFR, and growth factors sequences. The effect of peptides was screened using a mouse embryonic stem cell line expressing luciferase dual reporter construct driven by promoters for neural tubulin and for elongation factor 1. Cell number was estimated by measuring total cellular DNA. We identified five peptides which enhanced activities of both promoters without relevant changes in cell number. We selected the two most potent peptides for further analysis: the NCAM-derived mimetic FGLL and the synthetic NCAM ligand, Plannexin. Both compounds induced phenotypic neuronal differentiation, as evidenced by increased neurite outgrowth. In summary, we used a simple, but sensitive screening approach to identify the neurogenic peptides. These peptides will not only provide new clues concerning pathways of neurogenesis, but they may also be interesting biotechnology tools for in vitro generation of neurons.
Authors and Affiliations
Ruodan Xu, Maxime Feyeux, Stéphanie Julien, Csilla Nemes, Morten Albrechtsen, Andras Dinnyés, Karl-Heinz Krause
Keywords
Related Articles
- EP ID EP681079
- DOI 10.1208/s12248-014-9578-7
- Views 64
- Downloads 0
Genetic variations in human G protein-coupled receptors: Implications for drug therapy
Numerous genes encode G protein-coupled receptors (GPCRs)-a main molecular target for drug therapy. Estimates indicate that the human genome contains approximately 600 GPCR genes. This article addresses therapeutic impli...
Quantitative Pharmacology Approach in Alzheimer’s Disease: Efficacy Modeling of Early Clinical Data to Predict Clinical Outcome of Tesofensine
Effective therapeutic options for Alzheimer’s disease (AD) are limited and much research is currently ongoing. The high attrition rate in drug development is a critical issue. Here, the quantitative pharmacology...
Investigation of the Performance of the Disintegration Test for Dietary Supplements
The aim of this study was to investigate how beaker size, basket assembly, use of disk, and immersion medium impact the disintegration time of dietary supplements. The disintegration times were determined for five tablet...
The Utility of Modeling and Simulation Approaches to Evaluate Immunogenicity Effect on the Therapeutic Protein Pharmacokinetics
While therapeutic proteins (TP), particularly recombinant human proteins and fully human monoclonal antibodies, are designed to have a low immunogenic potential in humans, a clinical immune response does sometimes occur...
Protective Effects of Kaempferol on Isoniazid- and Rifampicin-Induced Hepatotoxicity
The online version of this article (doi:10.1208/s12248-013-9490-6) contains supplementary material, which is available to authorized users.